Atlas Trials

Pre-Treatment DCE-MRI AI Models Predict Neoadjuvant Chemotherapy Response in HR+/HER2- Breast Cancer

Clinical trial NCT07702708 · RECRUITING

Trial details

NCT number
NCT07702708
Sponsor
Fujian Cancer Hospital
Status
RECRUITING
Study type
OBSERVATIONAL
HR+/HER2- Breast CancerBreast Neoplasms
Start date
2026-06-01
Primary completion
2027-04-30
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.